G1 Therapeutics Q4 EPS $(0.67) Beats $(0.87) Estimate, Sales $16.55M Beat $4.06M Estimate
G1 Therapeutics Q4 EPS $(0.67) Beats $(0.87) Estimate, Sales $16.55M Beat $4.06M Estimate
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.87) by 22.99 percent. This is a 28.72 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $16.55 million which beat the analyst consensus estimate of $4.06 million by 307.54 percent.
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.87) by 22.99 percent. This is a 28.72 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $16.55 million which beat the analyst consensus estimate of $4.06 million by 307.54 percent.
G1治疗公司(纳斯达克：GTHX)公布季度亏损为每股0.67美元，比分析师普遍预期的(0.87美元)高出22.99%。这比去年同期每股亏损0.94美元增加了28.72%。该公司公布季度销售额为1,655万美元，比分析师普遍预期的406万美元高出307.54个百分点。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧